Phase II study of copanlisib, a PI3K inhibitor, in relapsed or refractory, indolent or aggressive lymphoma
| Image |  |
|---|---|
| Description | scientific article |
| Author/s |
author: Florian Hiemeyer Karl Köchert David Cunningham Kim Linton |
| Publication date | September 1, 2017 |
| Language | |
| Country of origin | |
| Wikipedia link | |
| Copyright status | |
| Missing/wrong data? | Edit Wikidata item |